Brief Title
Long Term Results of 450 Percutaneous Closures of PDA in a Single Center
Official Title
Long Term Results of 450 Percutaneous Closures of PDA in a Single Center
Brief Summary
Percutaneous closure is one of the methods used to treat, among other congenital heart disorder, Persistent Ductus Arteriosus (PDA) in children and adults. During the years 1998-2013 four hundred and fifty patients were catheterized in the department of pediatric cardiology and congenital heart diseases in Rambam health care campus, using various devices. In this retrospective research, the investigators analyze data from patients' medical files, to estimate and define the correlation between the patients' demographic and morphologic data to the type and size of chosen closure device. Aim of study: To create an algorithm that can be used to choose the proper device for percutaneous closure of the PDA, based on the characteristics of the patient and the PDA type.
Detailed Description
The investigators analyze the demographic characteristics of patients before the procedure (Age, gender, weight, height, co-morbidities etc.), the type and characteristics of PDA and the chosen device, success and failure rates of the procedure, and adverse effects. The data is taken from patients' medical files - based on medical reports regarding physical examination, blood tests and imaging studies including cineangiograms and echo-doppler studies.
Study Type
Observational
Primary Outcome
Success of implantation
Secondary Outcome
residual shunt
Condition
Patent Ductus Arteriosus
Publications
* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
Recruitment Information
Estimated Enrollment
450
Start Date
January 1998
Completion Date
August 2013
Primary Completion Date
August 2013
Eligibility Criteria
Inclusion Criteria: - All the patients that underwent percutaneous closure of PDA between January 1998 and august 2013 in the department of pediatric cardiology and congenital heart diseases in Rambam health care campus Exclusion Criteria: - None
Gender
All
Ages
N/A - N/A
Accepts Healthy Volunteers
No
Contacts
Moshe Dotan, MD, ,
Location Countries
Israel
Location Countries
Israel
Administrative Informations
NCT ID
NCT01929733
Organization ID
0192-13
Responsible Party
Sponsor
Study Sponsor
Rambam Health Care Campus
Study Sponsor
Moshe Dotan, MD, Principal Investigator, Rambam Health Care Campus
Verification Date
August 2013